EcoDrugPlus


Synonyms	Padeliporfin (potassium) Padeliporfin di-potassium Padeliporfin dipotassium Padeliporfin potassium Stakel WST-11 DIPOTASSIUM WST11 DIPOTASSIUM WST11 POTASSIUM
Status
Molecule Category	UNKNOWN
UNII	JQ72VD4XUL

Synonyms

Padeliporfin (potassium)

Padeliporfin di-potassium

Padeliporfin dipotassium

Padeliporfin potassium

Stakel

WST-11 DIPOTASSIUM

WST11 DIPOTASSIUM

WST11 POTASSIUM

Status

Molecule Category

UNKNOWN

UNII

JQ72VD4XUL


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Property Name	Value
Molecular Formula	C37H41K2N5O9PdS
Molecular Weight	916.44
AlogP	None
Hydrogen Bond Acceptor	None
Hydrogen Bond Donor	None
Number of Rotational Bond	None
Polar Surface Area	None
Molecular species	None
Aromatic Rings	None
Heavy Atoms	None

Property Name

Value

Molecular Formula

C37H41K2N5O9PdS

Molecular Weight

916.44

AlogP

None

Hydrogen Bond Acceptor

None

Hydrogen Bond Donor

None

Number of Rotational Bond

None

Polar Surface Area

None

Molecular species

None

Aromatic Rings

None

Heavy Atoms

None

Resources	Reference
ChEMBL	CHEMBL4594285
FDA SRS	JQ72VD4XUL
PubChem	129629432

Resources

Reference

ChEMBL

CHEMBL4594285

FDA SRS

JQ72VD4XUL

PubChem

129629432


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PADELIPORFIN POTASSIUM

Physicochemical Descriptors

Cross References